FDA offers advice to reduce risks of long-acting beta-agonists in asthma care.
Kuehn
Bridget M
BM
D000305:Adrenal Cortex Hormones / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D004347:Drug Interactions; D004348:Drug Labeling; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists